ED treatment comparison shows oral medications remain first-line therapy with 70-85% success rates, while peptide therapies and injectable treatments offer alternatives for men who don't respond to pills or want targeted approaches. PDE5 inhibitors like sildenafil cost $20-80 per dose in 2026, while peptide protocols range from $200-600 monthly through telehealth platforms. Oral medications work within 30-60 minutes for most men, but peptides like PT-141 target different pathways and may help when traditional pills fail. Injectable treatments including alprostadil achieve 85-90% success rates but require proper training and cost $30-50 per injection. The choice depends on your specific ED causes, other health conditions, and treatment goals.
Key Takeaways
- Oral PDE5 inhibitors work for 70-85% of men with ED and remain the standard first treatment
- Peptide therapies target different pathways and may help when traditional medications don't work
- Injectable treatments have higher success rates (85-90%) but require more preparation
- Cost varies significantly: pills $20-80 per use, peptides $200-600 monthly, injections $30-50 per dose
- Treatment choice should consider your ED causes, health conditions, and lifestyle preferences
Oral Medications: The Standard First-Line Treatment
PDE5 inhibitors including sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) work for 70-85% of men with erectile dysfunction. These medications block the enzyme phosphodiesterase type 5, allowing increased blood flow to the penis during sexual stimulation. Sildenafil and vardenafil typically work within 30-60 minutes and last 4-6 hours, while tadalafil can remain effective for up to 36 hours. Side effects occur in 15-20% of users and include headaches, flushing, nasal congestion, and occasional vision changes. Men taking nitrates for heart conditions cannot use PDE5 inhibitors due to dangerous blood pressure drops. Generic versions available in 2026 have reduced costs to $20-40 per dose, making oral medications the most cost-effective ED treatment for most men.Peptide Therapy: Targeting Different Pathways
Peptide therapy offers alternative mechanisms for treating ED beyond traditional blood flow approaches. PT-141 (bremelanotide) activates melanocortin receptors in the brain, potentially helping men whose ED stems from psychological or neurological factors rather than vascular issues. Clinical studies show PT-141 improves erectile function in 60-70% of men, with effects typically beginning 45-90 minutes after subcutaneous injection. BPC-157 shows promise for vascular repair and tissue healing, though specific ED research remains limited. Some practitioners combine multiple peptides in protocols targeting inflammation, hormone optimization, and vascular health. Monthly peptide programs through telehealth providers typically cost $200-600 in 2026, depending on the specific peptides included and dosing frequency.Injectable Treatments: Highest Success Rates
Intracavernosal injections directly deliver medication into the penis, achieving success rates of 85-90% even in men with severe vascular ED. Alprostadil (prostaglandin E1) is the most commonly used injectable, typically producing erections within 10-15 minutes that last 30-60 minutes. Trimix combinations containing alprostadil, phentolamine, and papaverine may work for men who don't respond to single-agent injections. Proper injection technique is essential to avoid complications like priapism (prolonged erections) or penile fibrosis. Most men learn self-injection within 2-3 training sessions with their healthcare provider. Costs range from $30-50 per injection in 2026, making this treatment more expensive per use than oral medications but potentially more reliable for men with severe ED.Testosterone Replacement: Addressing Hormonal Causes
Low testosterone affects 20-30% of men with ED, particularly those over 40. Sermorelin and Ipamorelin can stimulate natural testosterone production, while direct testosterone replacement therapy provides more immediate results for men with clinically low levels below 300 ng/dL. Testosterone therapy alone resolves ED in about 30-40% of hypogonadal men, but combination with PDE5 inhibitors often provides better results. Monitoring is essential as testosterone can worsen sleep apnea or increase prostate size in some men. Monthly testosterone therapy costs typically range from $150-400 in 2026 depending on the delivery method and monitoring requirements.Frequently Asked Questions
Which ED treatment has the best success rate?
Injectable treatments have the highest success rates at 85-90%, followed by oral PDE5 inhibitors at 70-85%. Peptide therapies show 60-70% success rates in clinical studies. However, the "best" treatment depends on your specific ED causes, health conditions, and preferences. Most doctors recommend starting with oral medications due to their convenience and proven track record.
Optimize your health with expert guidance
Get a personalized treatment plan after licensed provider review. Free consultation included.
Start Free Assessment →View data table
| Category | Relative Hormone Production (%) | Detail |
|---|---|---|
| 30-39 | 92 | Optimal hormone production |
| 40-49 | 78 | Gradual decline begins |
| 50-59 | 65 | Noticeable changes |
| 60-69 | 52 | Significant decline |
| 70+ | 38 | Marked reduction |
Can I combine different ED treatments safely?
Certain combinations can be safe and effective when properly supervised by a healthcare provider. Testosterone therapy plus PDE5 inhibitors is commonly used for men with low testosterone. However, combining oral medications with injections or using multiple PDE5 inhibitors simultaneously can cause dangerous blood pressure drops. Always consult your doctor before combining treatments.
How much do different ED treatments cost per month?
Monthly costs vary significantly based on usage frequency. Oral medications range from $80-320 monthly (assuming 4-16 uses), generic versions cost less. Peptide therapy runs $200-600 monthly through telehealth platforms. Injectable treatments cost $120-400 monthly depending on frequency. Insurance coverage varies, with many plans covering oral medications but fewer covering peptides or injections.
Do peptides work better than traditional ED pills?
Peptides target different pathways than traditional ED medications, making them potentially useful for men who don't respond to PDE5 inhibitors. However, oral medications have more extensive research and higher success rates overall. Peptides may be particularly helpful for ED with psychological or neurological components, but they're typically considered when first-line treatments haven't been effective.
What ED treatment works fastest?
Injectable treatments work fastest, producing erections within 10-15 minutes. Sublingual sildenafil can work in 15-30 minutes, while standard oral medications typically take 30-60 minutes. Peptides like PT-141 require 45-90 minutes to take effect. However, speed isn't the only consideration - convenience, duration, and side effects matter equally for most men choosing ED treatments.
Sources
- Burnett AL, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. PMID: 29746858
- Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-404. PMID: 9580646
- Diamond LE, et al. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141). J Sex Med. 2006;3(4):628-638. PMID: 16839319
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. PMID: 8596569
- Isidori AM, et al. A critical analysis of the role of testosterone in erectile function. Eur Urol. 2014;65(1):99-112. PMID: 24050791
- Porst H, et al. The Efficacy and Tolerability of Vardenafil. Int J Impot Res. 2001;13(4):192-199. PMID: 11494076
- Montorsi F, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy. J Urol. 2004;172(3):1036-1041. PMID: 15311039
- Corona G, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11(6):1577-1592. PMID: 24697970
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →